Does RIBOCICLIB Cause Neoplasm? 194 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 194 reports of Neoplasm have been filed in association with RIBOCICLIB (KISQALI). This represents 0.7% of all adverse event reports for RIBOCICLIB.
194
Reports of Neoplasm with RIBOCICLIB
0.7%
of all RIBOCICLIB reports
70
Deaths
72
Hospitalizations
How Dangerous Is Neoplasm From RIBOCICLIB?
Of the 194 reports, 70 (36.1%) resulted in death, 72 (37.1%) required hospitalization, and 35 (18.0%) were considered life-threatening.
Is Neoplasm Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIBOCICLIB. However, 194 reports have been filed with the FAERS database.
What Other Side Effects Does RIBOCICLIB Cause?
Neutropenia (3,585)
Nausea (3,404)
Fatigue (3,327)
Malignant neoplasm progression (2,468)
Death (2,452)
Vomiting (1,953)
Diarrhoea (1,830)
White blood cell count decreased (1,683)
Pain (1,637)
Metastases to bone (1,538)
What Other Drugs Cause Neoplasm?
ADALIMUMAB (513)
OCTREOTIDE (366)
RITUXIMAB (323)
LENALIDOMIDE (242)
CYCLOPHOSPHAMIDE (221)
BEVACIZUMAB (207)
INFLIXIMAB (201)
ETANERCEPT (194)
METHOTREXATE (165)
IMATINIB (164)
Which RIBOCICLIB Alternatives Have Lower Neoplasm Risk?
RIBOCICLIB vs RIBOFLAVIN
RIBOCICLIB vs RIBOFLAVIN 5'-PHOSPHATE
RIBOCICLIB vs RIBOFLAVIN 5^-PHOSPHATE
RIBOCICLIB vs RIFABUTIN
RIBOCICLIB vs RIFAMPICIN